Synthesis and antitumor evaluation of novel tetrahydrobenzo[4′,5′]thieno[3′,2′:5,6]pyrimido[1,2-<i>b</i>]isoquinoline derivatives
作者:Mahmoud R. Mahmoud、Fatma S. M. Abu El-Azm、Mahmoud F. Ismail、Mohamed H. Hekal、Yasmeen M. Ali
DOI:10.1080/00397911.2017.1406520
日期:2018.2.16
present study, a novel 8,9,10,11-tetrahydro-7H,14H-benzo[4′,5′] thieno[2′,3′:4,5]-1,3-oxazino[3,2-b]isoquinoline-7,14-dione 5 was prepared by condensation of 2-amino-3-carbethoxy-4,5,6,7-tetrahydrobenzothiophene with homophthalic anhydride under microwave irradiation, followed by alkaline hydrolysis and cyclization using acetyl chloride. Compound 5 was further allowed to react with different nitrogen nucleophiles
摘要 在本研究中,一种新型的 8,9,10,11-四氢-7H,14H-苯并[4',5']噻吩并[2',3':4,5]-1,3-恶嗪[3] ,2-b]isoquinoline-7,14-dione 5 是通过 2-amino-3-carbethoxy-4,5,6,7-四氢苯并噻吩与同邻苯二甲酸酐在微波辐射下缩合,然后用乙酰基水解和环化制备的氯化物。进一步让化合物5与不同的含氮亲核试剂反应得到新的四氢苯并噻吩并嘧啶异喹啉酮衍生物。制备的化合物的结构通过红外光谱、1H-NMR、13C-NMR和质谱进行了阐明。新制备的化合物在体外针对一组两种人类肿瘤细胞系进行了测试,即肝细胞癌(肝)HepG2 和乳腺乳腺 MCF-7。几乎所有的测试化合物都显示出令人满意的活性。